T1	intervention 45 68	hydrating nail solution
T2	condition 100 111	onycholysis
T3	eligibility 115 194	breast cancer patients who received neoadjuvant/adjuvant docetaxel chemotherapy
T4	outcome-Measure 1078 1110	incidence of onycholysis grade 2
T5	outcome-Measure 1115 1153	recovery rate from grade 2 onycholysis
T6	duration 1155 1183	From August 2015 to May 2016
T7	No-of-participants 1185 1188	103
T8	outcome 1278 1297	grade 2 onycholysis
T9	outcome 1260 1267	grade 1
T10	outcome 1385 1417	reduction of grade 2 onycholysis
T11	outcome 1581 1610	decreased grade 2 onycholysis
